Unicycive Therapeutics Statistics
Total Valuation
UNCY has a market cap or net worth of $112.14 million. The enterprise value is $151.82 million.
| Market Cap | 112.14M |
| Enterprise Value | 151.82M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
UNCY has 26.70 million shares outstanding. The number of shares has increased by 116.57% in one year.
| Current Share Class | 26.70M |
| Shares Outstanding | 26.70M |
| Shares Change (YoY) | +116.57% |
| Shares Change (QoQ) | +11.56% |
| Owned by Insiders (%) | 2.36% |
| Owned by Institutions (%) | 25.22% |
| Float | 22.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 1.99 |
| PS Ratio | n/a |
| Forward PS | 1.54 |
| PB Ratio | 5.15 |
| P/TBV Ratio | 5.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.40 |
| Quick Ratio | 2.06 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -535.09 |
Financial Efficiency
Return on equity (ROE) is -163.14% and return on invested capital (ROIC) is -74.41%.
| Return on Equity (ROE) | -163.14% |
| Return on Assets (ROA) | -40.56% |
| Return on Invested Capital (ROIC) | -74.41% |
| Return on Capital Employed (ROCE) | -79.02% |
| Weighted Average Cost of Capital (WACC) | 13.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.81M |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.85% in the last 52 weeks. The beta is 1.73, so UNCY's price volatility has been higher than the market average.
| Beta (5Y) | 1.73 |
| 52-Week Price Change | -39.85% |
| 50-Day Moving Average | 7.50 |
| 200-Day Moving Average | 6.25 |
| Relative Strength Index (RSI) | 29.17 |
| Average Volume (20 Days) | 1,972,485 |
Short Selling Information
The latest short interest is 3.24 million, so 12.12% of the outstanding shares have been sold short.
| Short Interest | 3.24M |
| Short Previous Month | 2.84M |
| Short % of Shares Out | 12.12% |
| Short % of Float | 14.14% |
| Short Ratio (days to cover) | 3.88 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -29.97M |
| Pretax Income | -39.95M |
| Net Income | -39.89M |
| EBITDA | -29.93M |
| EBIT | -29.97M |
| Earnings Per Share (EPS) | -$2.11 |
Balance Sheet
The company has $54.59 million in cash and $815,000 in debt, with a net cash position of $53.77 million or $2.01 per share.
| Cash & Cash Equivalents | 54.59M |
| Total Debt | 815,000 |
| Net Cash | 53.77M |
| Net Cash Per Share | $2.01 |
| Equity (Book Value) | 37.70M |
| Book Value Per Share | 1.49 |
| Working Capital | 37.06M |
Cash Flow
In the last 12 months, operating cash flow was -$28.66 million and capital expenditures -$16,000, giving a free cash flow of -$28.67 million.
| Operating Cash Flow | -28.66M |
| Capital Expenditures | -16,000 |
| Depreciation & Amortization | 34,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -28.67M |
| FCF Per Share | -$1.07 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
UNCY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -116.57% |
| Shareholder Yield | -116.57% |
| Earnings Yield | -19.40% |
| FCF Yield | -13.95% |
Analyst Forecast
The average price target for UNCY is $41.30, which is 883.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.30 |
| Price Target Difference | 883.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 20, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 20, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |